VZ-564

N/A

Report date: 2022/08/23 20:00:44

NME

Base Information

Drug NameVZ-564

Drug Alias NameN/A

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionArachidonate 5-lipoxygenase inhibitors

TargetsArachidonate 5-lipoxygenase

Therapy Area/IndicationsAsthma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryGermany

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesGrunenthal Gmbh

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesGrunenthal Gmbh

Active IndicationsN/A

Inactive IndicationsAsthma

ATC CodeN/A